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Oxidative stressDuring normal B- and T-cell life, processes including activation, proliferation, signaling pathways and apoptosis
are markedly dependent on ROS generation. However, these cells can also suffer the effect of oxidant
overproduction. Thus, the purpose of the present study was to examine the possible pro-oxidant effects of
MGO/high glucose and antioxidant effects of astaxanthin associated with vitamin C on some oxidative and anti-
oxidant parameters of human lymphocytes in vitro. Lymphocytes from healthy subjects were treated with
20 mM of glucose and 30 μMMGO followed or not by the addition of the antioxidants astaxanthin (2 μM) and
vitamin C (100 μM) for up to 24 h.We examined superoxide dismutase (SOD), catalase, glutathione peroxidase,
glutathione reductase, and glucose-6-phosphate dehydrogenase (G6PDH) activities, GSH/GSSG ratio and total
thiol and carbonyl content. Oxidative parameters included superoxide anion, hydrogen peroxide and nitric
oxide production. The association of astaxanthin and vitamin C proved to be a powerful antioxidant in human
lymphocytes as showed by the marked reduction in superoxide anion, and hydrogen peroxide production as
well as increased GSH content, GSH/GSSG ratio, GPx and GR activities. The antioxidant association showed to
be more potent than their individual application. High glucose and methylglyoxal did not promote oxidative
stress in human lymphocytes, since neither the oxidative parameters nor the antioxidant defense system was
altered. According to these results, new therapieswith the association of astaxanthin and vitamin Cmay be helpful
to improve the immune function of patients with exacerbated production of ROS.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Several functions of the lymphocytes, such as clonal expansion,
orchestration of the immune response and antibody production,
are strongly inﬂuenced by the intracellular and microenvironmental
oxidant/antioxidant status. Immune cells, among them lymphocytes
are well known as an important source of both oxidant and pro-
inﬂammatory compounds needed to support their functions. During
normal B- and T-cell life, processes including activation, proliferation,
signaling pathways, antibody production and apoptosis are markedly
dependent on ROS generation [1]. However, these cells can also suffer
the effect of oxidant overproduction. Thus, immune cells need to deal
appropriately with this delicate balance between beneﬁcial and
hazardous effects of ROS [2]. The ability to handle oxidative stress de-
pends on mechanisms of protection either endogenously or provided
by diet [3]. Therefore, antioxidant levels are important to maintain
redox homeostasis and, therefore, adequate function of lymphocytes
[4].ão Paulo, SP 03342000, Brazil.
r (R. Otton).
evier OA license.Natural compounds have been proposed as potential therapeutic
agents in the prevention and/or treatment of a number of diseases. The
increase of antioxidant status, which is achieved through sufﬁcient intake
of antioxidants, has been hypothesized to play an important role in the
protection against chronic disease in humans [5]. Astaxanthin (ASTA),
3,3'-dihydroxy-ß-carotene-4,4'-dione, can be found abundantly in the
reddish-orange pigment of marine animals, such as microalgae, fungi,
complex plants, and crustaceans [6]. ASTA has potential clinical applica-
tions due to its antioxidant activity, which is higher than β-carotene
and α-tocopherol [7,8]. Astaxanthin-carotenoid has many highly potent
pharmacological effects, including cardioprotective, neuroprotective,
anti-tumor, anti-cancer, anti-diabetic, anti-inﬂammatory and immuno-
modulatory actions [7,9–12].
The presence of hydroxyl (OH) and keto (C_O) in each ionone
ring in ASTA explains its unique feature of antioxidant activity for
the protection of both the inner and outer membrane surfaces [13].
Studies from our group that evaluated the antioxidant effect of
astaxanthin on human leukocytes and animal models showed a mod-
est antioxidant effect [12,14–18], mainly by decreasing superoxide
and hydrogen peroxide production.
While astaxanthin is essentially a membrane-bound antioxidant
[19], vitamin C is a potent water soluble antioxidant [20] involved
in several biological functions. Vitamin C (ascorbic acid) has attracted
great interest for its useful physiological and pharmacological
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cesses, including the immune response [21]. Ascorbic acid reduces
ROS/RNS by donating its electron, preventing other compounds
from being oxidized. In addition to scavenging ROS/RNS, vitamin C
can regenerate other small molecule antioxidants, such as
α-tocopherol, glutathione (GSH), urate [22], and β-carotene, from
their respective radical species [23]. However, whether astaxanthin
membrane-bound antioxidant can also be regenerated by vitamin C
in a similar vitamin C/vitamin E system has not been studied yet.
Increasing evidence has connected oxidative stress to a variety of
pathological conditions, including diabetes mellitus. Methylglyoxal
(MGO) is a highly reactive dicarbonyl metabolite produced during
glucose metabolism [24]. It is physiologically present in all biological
systems, being formed by the enzymatic and non enzymatic elimina-
tion of a phosphate from triose-phosphate glycolytic intermediates
and by the oxidation of aminoacetone formed in the catabolism of
threonine amino acid [25]. In insulin-resistant states, such as obesity
and type 2 diabetes, altered glucose metabolism may lead to in-
creased formation of methylglyoxal and other α-ketoaldehydes. In-
deed, the concentration of methylglyoxal in diabetic patients'
plasma is increased proportionally with the glycemic level [26].
The clinical signiﬁcance of MGO lies in the fact that it reacts with
and modiﬁes certain proteins, lipids and DNA, and alters their normal
structure and/or function [24,27]. MGO is a major precursor of the
advanced glycation endproducts (AGEs), which are involved in the
pathogenesis of the vascular complications of diabetes [24,27]. Dia-
betic patients also suffer from many common infections, whose
causes remain unknown. One hypothesis suggested that the damage
would be caused by immune glycation and may be responsible for in-
creased susceptibility to infections [28,29]. Furthermore, an increase
in MGO concentration may disrupt the intracellular redox balance,
since the detoxiﬁcation of MGO by an enzyme system known as
glyoxalases, uses the tripeptide glutathione to degrade MGO and to
form less reactive compounds, possibly reducing the endogenous an-
tioxidant defenses of cells. Several authors also showed that MGO can
be a direct source of ROS or can activate several intracellular path-
ways that generate reactive species and thus induce oxidative stress
[30]. Although there is much evidence of the effects of MGO on sever-
al immune cell types, there are no data reporting the effects of the
combination of high glucose with MGO on the endogenous oxidant/
antioxidant parameters of lymphocytes. As mentioned before, glucose
is a natural endogenous source of MGO. Thus, the purpose of the
present study was to examine the possible pro-oxidant effects of
MGO/high glucose and antioxidant effects of astaxanthin associated
with vitamin C on some oxidative and antioxidant parameters of
human lymphocytes in vitro.
2. Materials and methods
2.1. Reagents
Methylglyoxal, D-glucose, astaxanthin, dihydroethidium, vitamin
C, propidium iodide and most of the other chemicals were purchased
from Sigma-Aldrich Chemical Company (St. Louis, MO), except the
RPMI-1640 culture medium, which came from Invitrogen (CA, USA).
Common reagents for buffers (e.g. PBS) and regular laboratory solu-
tions were obtained from Labsynth (Diadema, SP, Brazil).
2.2. Subjects
The Ethical Committee of the Universidade Cruzeiro do Sul ap-
proved the experimental procedure of this study (128/2009). Around
30 healthy adult women and men (mean age 21.0±4.0) were includ-
ed in the present study. None of the subjects had not undergone sys-
temic or topical therapeutic regimen at least for the last 2 months.
Based on an anamnesis protocol, subjects with a smoking history,alcohol habits, obesity or any other systemic diseases were excluded
from the study.
2.3. Cell isolation and culture condition
Lymphocytes were obtained through the collection of human pe-
ripheral blood by venipuncture procedure in vacuum/siliconized
tubes containing 0.1 mM EDTA. Peripheral blood lymphocytes were
isolated as previously described [12]. After isolation, cells were treat-
ed with 2 μM of astaxanthin, 100 μM of vitamin C, 20 mM of glucose
and 30 μM of methylglyoxal and cultured at 5% CO2 for up to 24 h
at 37 °C. After this period, the cells were collected, centrifuged
and stored at −80 °C. For the assays of enzyme activities and oxida-
tive damage in biomolecules, cells were defrosted and immediately
used. For the acute effects on cell ROS production, after isolation,
lymphocytes were resuspended in Tyrode's solution (137 mM NaCl,
2.68 mM KCl, 0.49 mM MgCl2, 12 mM NaHCO3, 0.36 mM NaH2PO4,
5.6 mM D-glucose, and 5 mM acid HEPES, pH7.4) and immediately
used. Astaxanthin was solubilized in DMSO while vitamin C, glucose
and methylglyoxal were solubilized in Tyrode's solution for short
periods or in RPMI-1640 medium for long periods (24 h).
The concentration of astaxanthin used in the present study was
previously described [12]. Vitamin C, glucose and MGO were deter-
mined by a viability curve using different concentrations of these
compounds. This test was performed by exclusion of Trypan Blue
(data not shown) after 24 h of culture.
2.4. Cell membrane integrity
Cell viability was assessed by using ﬂow cytometer to conﬁrm if
the concentration of the treatments chosen for the experiments did
not cause toxicity in lymphocytes. Immediately after being obtained
and at the end of the culture period (24 h), cells (1×106/mL) were
used to test the membrane integrity. This assay was carried out as
previously described [12].
2.5. Oxidative parameters — ROS/RNS production
Superoxide anion production was measured after PMA stimulation
(20 ng/well) by using dihydroethidium (DHE) and lucigenin probes
according to Bolin et al. [12]. DHE assay was performed either freshly
(1 h) and after 3 and 18 h of cell treatment with MGO+high glucose
in order to check ASTA+Vit. C protective capacity. We also performed
an assay in which cells were prior treated with the antioxidants for 3
and 18 h and after challenged with oxidants for additional 18 h. This
assaywas carried out to assess the possible prophylactic effect of the an-
tioxidants. As an internal control, DPI (diphenyleneiodonium 10 μM),
an inhibitor of NADPH oxidase [31], sodium azide (SA — 400 μM), a
complex III electron transport chain inhibitor, and rotenone (RT —
5 μM), a complex I electron transport chain inhibitor, were added to
the cells to investigate if superoxide anion production occurred through
NADPH-oxidase or mitochondria activation. EGTA (ethylene glycol
tetraacetic acid, 500 μM) was used as a calcium chelator to answer if
the intracellular superoxide anion production is a calcium-dependent
process. Additionally, to ensure the speciﬁcity of DHE and lucigenin
to superoxide anion, hydrogen peroxide (50 μM) was added to control
cells. Fluorescence of DHE emission was analyzed in a microplate
reader (Tecan, Salzburg, Austria) at 590 nm (excitation wavelength at
396 nm). Results are expressed as relative ﬂuorescence units (RFU).
Chemiluminescence of the excited product of lucigenin oxidation by
O2•− was monitored for 60 min in a luminometer (Tecan, Salzburg,
Austria) and expressed as chemiluminescence relative units.
DCFH-DA probe was used to measure intracellular hydrogen perox-
ide production according to Campoio et al. [16]. Positive controls were
assessed using H2O2 (50 μM) and a combination of NO-donor,
S-nitroso-N-acetyl-penicillamine (SNAP; 6 nM)+PMA (100 ng), as an
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Fig. 1. Membrane integrity scores (PI ﬂuorescence) as indexes of ASTA+Vit. C,
Gluc+MGO and AVGM cytotoxicity in human lymphocytes cultured for 24 h. The
cells (1×106/mL) were treated with astaxanthin (2 μM)+vitamin C (100 μM), glucose
(20 mM)+methylglyoxal (30 μM)and astaxanthin+vitaminC+glucose+methylglyoxal.
Results are presented as mean±SEM of 3 experiments performed in triplicate.
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by adding NAC (N-acetylcysteine; 500 μM) and NAC+H2O2 (500 μM
and50 μM, respectively). The resultswere expressed as relativeﬂuores-
cence units (RFU). NO• production was performed according to Ding
[32] as previously described [12].
In all experiments lymphocytes (5×105/well) were cultured with
or without ASTA (2 μM), Vit. C (100 μM), glucose (20 mM) and MGO
(30 μM) and stimulated with PMA (20–50 ng/well) or LPS (lipopoly-
saccharide; 20 μg/well).
2.6. Antioxidant defenses
2.6.1. Preparation of homogenates for measurement of antioxidant
enzymes, oxidative lesions and glutathione content
Lymphocytes (5×106/mL) were cultured in the presence of
ASTA+Vit. C, Gluc+MGO and AVGM for 24 h. After the culture period
(24 h), lymphocytes were harvested, and the cells were ruptured
by ultra-sonication in a Vibra Cell apparatus (Connecticut, USA)
using 500 μL of the assay-speciﬁc extraction solution/buffer, and then
centrifuged for 10 min, 10,000× at 4 °C. The supernatant was used for
further analysis.
2.6.2. Antioxidant enzyme activity
Superoxide dismutase (SOD), catalase (CAT), glutathione peroxi-
dase (GPx) and glutathione reductase (GR) activities were determined
in lymphocytes using a microplate reader (Tecan, Salzburg, Austria).
CAT activitywasmeasured as described by Aebi [33] based on the direct
decomposition of hydrogen peroxide (H2O2). SOD activity was mea-
sured using the method described by Ewing and Janero [34], which in-
volves the reduction of O2•− radicals by nitroblue tetrazolium (NBT)
following a linear ﬁrst order kinetic during 3 min. Glutathione peroxi-
dase [35] and glutathione reductase [36] activities were measured
based on the oxidation of β-NADPH in the presence of tert-butyl hydro-
peroxide used as substrate.
2.6.3. GSH and GSSG content
Reduced (GSH) and oxidized (GSSG) glutathione contents in lym-
phocytes were measured as described by Rahman et al. [37]. The
method is based on the reaction between reduced thiol groups
(such as in GSH) with 5,5-dithiobis-2-nitrobenzoic acid (DTNB) to
form 5-thio-2-nitrobenzoic acid (TNB), which is stoichiometrically
detected by absorbance at 412 nm. Puriﬁed GSH and GSSG were
used as standards.
2.6.4. Glucose-6-phosphate dehydrogenase (G6PDH) activity
Glucose-6-phosphate dehydrogenase (G6PDH), EC 1.1.l.49, is a key
regulatory enzyme of the oxidative segment of the pentose-phosphate
pathway and produces reducing equivalents in the form of NADPH to
meet some cellular needs for reductive biosynthesis and as a contribu-
tion to the maintenance of the cellular redox state. G6PDH activity
was measured according to [18] and was based on the conversion of
NADP+ in NADPH in the presence of glucose-6-phosphate.
2.6.5. Oxidative damage
Thiol group and protein carbonyl formation groups were evaluat-
ed as biomarkers of amino acid oxidation in total protein fractions,
which were isolated from crude homogenate of cells (5×106) by
precipitation with 20% trichloroacetic acid solution in ice. Reduced
thiol groups were detected by the formation of colored adducts
after reaction with 4 mM 5.5′-dithio-(2-nitrobenzoic acid) solution
(DTNB). The absorbance of DTNB-treated samples at 412 nm was cal-
culated using GSH as a standard [38]. The same procedure was used to
estimate protein carbonyls. The protein carbonyls were identiﬁed by
the hydrazones formed with 10 mMDNPH in 0.25 M HCl. Absorbance
of the peak detected within the range of 340–380 nm was measured,and the carbonyl group concentration was calculated based on the
molar coefﬁcient of ε=2.2×104 M−1 cm−1 [39].
2.6.6. Protein measurement
The total protein content of cells was measured by the method of
Bradford, using BSA as standard [40].
2.7. Statistical analyses
All data presented are the mean values with standard errors of
at least three independent experiments. The data were analyzed by
one-way ANOVA followed by Tukey's post-test. The software employed
for statistical analysiswasGraphPadPrism(version4;GraphPad Software,
San Diego, CA, USA).
3. Results
3.1. Cell membrane integrity
In vitro cytotoxicity test is useful and necessary to evaluate the in-
trinsic ability of a compound to cause death and consequence damage
to basic cellular functions [41]. Cell viability was assessed after 24 h of
culture in the presence or absence of 2 μM of astaxanthin, 100 μM of
vitamin C, 20 mM of glucose and 30 μM of MGO. Fig. 1 indicates that
there was no signiﬁcant loss of cell membrane integrity among all
groups. This result assures that the concentrations selected do not
cause cytotoxicity/death of human lymphocytes. Individual analysis
with each chemical was assessed by Trypan Blue exclusion and re-
vealed the same proﬁle (data not shown).
3.2. Oxidative parameters
Many authors have shown that ROS formation is essential for a
proper function of both T- and B-lymphocytes [42–44]. Reactive oxy-
gen species are not only harmful as mediators of oxidative stress, but
also have immune-regulatory functions, especially when produced
in small amounts [24,42,44]. In order to investigate whether the pro-
duction of O2• , H2O2 and NO• can be altered by the addition of antioxi-
dants and/or oxidant, freshly isolated lymphocytes were acutely
treated with ASTA+Vit. C and/or Gluc+MGO as indicated in the
Materials and methods section.
As shown in Fig. 2A, the intracellular superoxide anion production
measured by DHE probe in freshly PMA-treated lymphocytes was re-
duced by 49% and 59% in the groups ASTA+Vit. C and AVGM, respec-
tively, when compared to the PMA-control group. Alone, ASTA and
vitamin C did not have the same effectiveness in reducing superoxide
anion production. However, vitamin C demonstrated to bemore potent
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further elucidate the proper period to ASTA exerts its antioxidant effect,
we treated lymphocytes in the presence of the antioxidants for 3 andUnstimulated PMA-stimulated DPI SA+RT EGTA H2O2
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Fig. 2. Intracellular superoxide anion production assayed by DHE probe in freshly-treated c
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to properly/fully load ASTA in cell membranes as showed by the re-
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ASTA was more pronounced. ASTA and Vit. C alone had the same
efﬁciency in reducing intracellular superoxide, although, the
association of them improved the antioxidant effect. These results
emphasized that the association of ASTA+Vit. C had a pronounced
antioxidant effect compared to antioxidants alone. Also, that ASTA
requires time to be completely inserted into cell membranes
and exert better antioxidant effect. The association of glucose with
MGO did not cause increase in the oxidation of DHE probe even in
cells pre-treated with oxidants for 18 h prior to the treatment with
antioxidants (Fig. 2C).
PMA-stimulated control cells pre-treatment with DPI (a NADPH-
oxidase inhibitor) completely inhibited superoxide anion production
whereas the addition of sodium azide+rotenone (inhibitors of mito-
chondrial complexes I and III, respectively), partially inhibited super-
oxide production (Fig. 2A). EGTA, a calcium chelator, had no effect
on superoxide production induced by PMA, demonstrating that this
phenomenon is not dependent on calcium release. H2O2 was used
as a control of the speciﬁcity of DHE probe. As indicated, DHE is
more sensitive to superoxide anion than H2O2.
To evidence the prophylactic effects of antioxidant-rich nutrition
against immune suppression in ROS-mediated diseases seen in
diabetes, lymphocytes were pre-treated for 18 h in the presence of
the antioxidants followed by oxidative challenges imposed by
Gluc+MGO for 18 h more (Fig. 2D). The proﬁle observed in the
ASTA+Vit. C and Gluc+MGO groups was the same as observed in
freshly assays and convinced us that ASTA and Vit. C have notable
antioxidant effects when administered together and that high
glucose and MGO do not cause changes in the redox state of
lymphocytes.
Lucigenin probe (Fig. 2E) was used to measure the activation of
NADPH-oxidase and then extracellular superoxide anion production.
For this purpose lymphocytes were stimulated with PMA. ASTA+Vit.
C and AVGM promoted a reduction in the superoxide anion production
as compared with the control-PMA group (48 and 55%, respectively),
whereas glucose with MGO did not increase lucigenin oxidation.
Astaxanthin alone was responsible for the decrease in the extracellular
superoxide anion production (data not shown). DPI (10 μM) addition
30 min before the treatment with PMA promoted a total inhibition in
the lucigenin signal, indicating that indeed, superoxide anion produc-
tion occurred via the NADPH-oxidase activation. Hydrogen peroxide
did not promote a lucigenin light emission, indicating the speciﬁcity
of the lucigenin probe to the superoxide anion present in the extracellu-
lar compartment.
A similar pattern was observed in DCFH-DA used as an intracellular
H2O2 probe (Fig. 2F). The association between ASTA and Vit. C was able
to reduce about 72% of the H2O2 production in PMA-stimulated cells,
compared to respective control group. The increase observed in the
Gluc+MGO group was drastically reduced by the presence of the anti-
oxidants (77%). Both reductions were due to the action of vitamin C,
which when added alone accounted for 70% decrease of H2O2 produc-
tion (data not shown). Internal controls were carried out to determine
the speciﬁcity of the probe. For this purpose, hydrogen peroxide andTable 1
Antioxidant enzyme activities of lymphocytes. The results are presented as mean±SEM of 4
ASTA+Vit. C group, and (c) compared to Gluc+MGO group.
Cont
Total/SOD (U mg protein−1) 3.73±0.36
CAT (μmol H2O2.min−1 L−1 mg protein−1) 29.35±1.32
GPx (mU mg protein−1) 22.82±1.65
GR (mU mg protein−1) 271.20±30.46 2
G6PDH (mU mg protein−1) 10.73±0.89SNAP+PMA were used. DCFH-DA presented greater sensitivity to
hydrogen peroxide. Interestingly, treatment with ASTA+Vit. C had the
same effectiveness to prevent ROS generation as the pre-treatment
with N-acetylcysteine (NAC), a potent ROS scavenger.
NO• production was evaluated in cells at LPS-stimulated condi-
tions (Fig. 2G). After LPS-stimulation there was no difference in NO•
production compared to LPS-control group.3.3. Antioxidant defenses
In order to assess the redox balance, we measured the antioxidant
enzyme activities in human lymphocytes (Table 1). Maximal activity
of total/SOD was not altered by any of the treatments after 24 h
of culture. Association of ASTA and vitamin C provided the most
signiﬁcant effects, inducing a decrease in CAT activity (54%) and a
massive increment in GPx (143%) and GR (8.3-fold) activities. Indi-
vidually, ASTA and Vit. C had different proﬁles in each enzyme; they
reduced CAT activity as well as GPx activity, while GR activity was
enhanced (data not shown). Combined treatment with glucose
and methylglyoxal was responsible for improving GR activity about
3-fold (Table 1), while individually they decreased GPx activity
(data not shown). Addition of ASTA+Vit. C in Gluc+MGO group
decreased 32% of CAT activity and increased 91% of GR activity as
compared with Gluc+MGO. There was a decrease in GPx and GR ac-
tivities of 60 and 32%, respectively when compared to ASTA+Vit. C
group.
Glutathione tripeptide is one of the most important antioxidants
in cellular system. Therefore, to understand glutathione status it is
necessary to measure both reduced and oxidized forms of glutathi-
one. Glutathione redox status was analyzed after 24 h of treatment
(Fig. 3). ASTA+Vit. C increased GSH and decreased GSSG content
about 59% and 30%, respectively, and maintained an elevated GSH/
GSSG ratio (54%). However, this beneﬁcial effect was only due to
vitamin C action (data not shown). GSH and GSSG contents were de-
creased in the presence of Gluc+MGO (42% and 40%, respectively).
Methylglyoxal alone was responsible for the decrease of GSSG con-
tent (data not shown). GSH/GSSG ratio was not altered by this treat-
ment, keeping the control levels. AVGM treatment caused an increase
of 44% and 69% in GSSG content as compared with ASTA+Vit. C and
Gluc+MGO, respectively. GSH content andGSH/GSSG ratio, on the other
hand, were decreased in comparison to control and ASTA+Vit. C (GSH—
51% and 69% and GSH/GSSG ratio — 41% and 62%, respectively).
Another important enzyme in the redox system is G6PDH
(Table 1). This enzyme is responsible for the production of the
co-factor NADPH, used in the regeneration of glutathione cycle. The
association of ASTA+Vit. C was responsible for an increment in
G6PDH activity (107%). Individual treatment presented a different
proﬁle, that is, while ASTA was responsible for the decrease of
G6PDH activity, vitamin C maintained it in the control levels (data
not shown). Gluc+MGO did not alter G6PDH activity even in the
presence of the antioxidants (AVGM group). None of the treatments
altered the oxidative damage in biomolecules (Table 2).experiments performed in triplicate. (a) Compared to control group, (b) compared to
ASTA+Vit. C Gluc+MGO AVGM
4.49±0.37 5.50±0.63 5.38±0.51
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Fig. 3. GSH, GSSG concentration and GSH/GSSG ratio in human lymphocytes after 24 h
of treatment with ASTA+Vit. C, Gluc+MGO and AVGM. (a) pb0.05 compared to con-
trol group, (b) pb0.05 compared to ASTA+Vit. C group, and (c) pb0.05 compared to
Gluc+MGO group.
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Lymphocytes must to be able to rapidly respond to the presence
of pathogens, changing from a quiescent phenotype to a highly active
state within hours [45]. This process is essentially dependent on ROS
molecules which can be produced within T- and B-cells or be absorbed
from the extracellular space at varying concentrations. At physiological
levels, ROS are involved in T cell signaling andmaintaining homeostasis,
acting also as a second messenger [46]. Nevertheless, excessive ROS
production can attack cellular components of the lymphocytes leading
to cell damage or improper lymphocyte function. The effects of oxida-
tive stress on suppressed signal transduction, transcription factor activ-
ities, and decreased cytokine production in response to nonspeciﬁc and
Ag-speciﬁc stimulation in T cells have been documented in several
model systems [47].
The current study investigatedwhether high glucose/methylglyoxal
and an association of the antioxidants astaxanthin and vitamin C can
alter ROS production, biomarkers of oxidative damage and endogenous
antioxidant defense system of human lymphocytes. The results of
this study provide evidence that the association of the antioxidants
astaxanthin and vitamin C proved to be a powerful antioxidant in
human lymphocytes (Fig. 2 and Table 1) as showed by the marked re-
duction in superoxide anion, and hydrogen peroxide production as
well as increased GSH content, GSH/GSSG ratio, GPx and GR activities.
The antioxidant association showed to be more potent than their indi-
vidual application (data not shown). Antioxidants are pivotal in
maintaining redox balance by either preventing the formation of free
radicals, detoxifying them, or by scavenging the reactive species or
their precursors [48]. In our model the astaxanthin/vitamin C system
mimics the recycling system of vitamin E/vitamin C. Experimental stud-
ies conﬁrm that ASTA has a large capacity to neutralize free radical or
other oxidant activity in the nonpolar (“hydrophobic”) zones of phos-
pholipid aggregates, aswell as along their polar (hydrophilic) boundary
zones [49], while vitamin C promotes antioxidant effects mainly in
water-phase microenvironment. Some authors [50,51] clearly indicate
that physiological concentrations of antioxidants located in the aqueous
and lipid compartments interact synergistically to protect cellular struc-
tures against oxidation of reconstituted human serum, indicating thatTable 2
Oxidative damage in biomolecules of lymphocytes. The results are presented as mean±SEM
Cont
Protein-SH (nmol SH.mg protein−1) 124.20±12.97
Protein C_O (μmol C_O.mg protein−1) 19.07±1.31this interaction ismore biologically relevant because itmaintains the in-
tegrity of the hydrophilic and lipid compartments.
In fact, a concern about ASTA is exactly if it needs to be properly/
fully loaded in cell membrane to exert its antioxidant effect. ASTA
can be a quencher as well as a scavenger of ROS, exerting its function
even when it is not properly loaded in the cell membranes. Previous
studies demonstrated the remarkable action of astaxanthin during
the activation of NADPH-oxidase in different cell types by using
lucigenin extracellular probe [12,14]. In our study a proper time of
more than 3 h was needed for ASTA to exert more powerful antioxi-
dant effect against intracellular ROS production.
In the present study the treatment of lymphocytes with high
glucose/MGO did not cause a change in the production of ROS/RNS.
Different approaches performed in this study were not able to induce
a signiﬁcant stress in cells treated with MGO+high glucose, as
evidenced by the increased time of treatment with oxidants as well
as the pre-treatment with the oxidant agents (Fig. 2A, C and D). Con-
trasting observations were made by other authors who showed that
high glucose/MGO increased ROS production and oxidative stress in
different cell types [52]. MGO-inducer of intracellular ROS production
and oxidative stress can occur via (i) the glycation reaction of MGO
with amino acids or proteins, (ii) depletion of glutathione during
MGO metabolism, (iii) MGO-induced modiﬁcation or inactivation of
ROS scavenger enzymes and (iv) the emergence of genotoxicity that
ends in carcinogenicity [53]. We treated lymphocytes with a high
dose of glucose (20 mM) associated with 30 μM MGO trying to
mimic the hyperglycemic state. However, the treatment was carried
out for a relative short period (up to 24 h), compared to the time re-
quired for MGO to act as a glycation agent. Perhaps a short period
contributes to the absence of deleterious effects in lymphocytes. In
addition, a study showed that as little as 3% of exogenous MGO was
absorbed by cultured L6 muscle cells incubated with 2.5 mM MGO
[54]. Therefore, we can also assume that the MGO concentration
used in this study (30 μM), lower as compared with the other studies
[55–57], resulted in low MGO uptake by lymphocytes, not causing
any ROS production or oxidative stress.
Also, lymphocytes usually use glucose and glutamine as their pri-
mary fuel source [30], although ketone bodies and fatty acids can also
be used to a small degree. Among these nutrients, glucose appears to
be particularly necessary for cell survival, activation, and cytokine
production [58]. Glucose provides much-needed energy for the lym-
phocyte in the following ways: (1) glucose can serve as a primary
substrate for the generation of ATP; (2) glucose can supply a carbon
source for the synthesis of other macronutrients, such as nucleic
acids and phospholipids; and (3) glucose can be metabolized by the
pentose phosphate pathway to generate NADPH [58]. In our study,
lymphocytes treated with high glucose did not show increment in
G6PDH activity. Whether glucose is being used as an ATP source or
in the biosynthesis of macromolecules remains to be elucidated.
The inactivation/destruction of ROS is generally dependent on the
endogenous antioxidant system such as antioxidant enzymes superox-
ide dismutase, catalase and glutathione reductase, as well as sufﬁcient
supply of NADPH. Antioxidant enzymes protect a variety of tissues in
the body against oxidative damage. Superoxide dismutase scavenges
the superoxide radical by converting it into H2O2 to its subsequent de-
toxiﬁcation. Aerobic cells contain high amounts of two main antioxi-
dant enzymes, SOD and catalase. In our study the activity of SOD wasof 4 experiments performed in triplicate.
ASTA+Vit. C Gluc+MGO AVGM
93.53±7.58 83.99±8.43 92.17±9.04
15.33±0.91 17.74±0.99 18.49±1.39
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creased in lymphocytes treated with astaxanthin/vitamin C. A previous
work from our group using 5 μM of ASTA demonstrated an increase in
SOD activity and a slight decrease in O2•− production [12]. A direct inac-
tivation of superoxide by antioxidants astaxanthin and vitamin C could
be responsible for the lower production of superoxide accompanied by
anunchanged SODactivity. At the same timeGPx andGRactivitieswere
markedly increased after ASTA plus vitamin C application. Therefore,
how could the application of ASTA+Vit. C has signiﬁcantly increased
the glutathione redox system of lymphocytes, as shown in this study?
Perhaps the answer to this question can be related to the way
in which vitamin C is transported into lymphocytes. Intracellular
accumulation of ascorbic acid seems to occur via two separate trans-
port pathways: dehydroascorbic acid (DHA) transport, oxidized
form of ascorbate, and ascorbic acid transport [59]. Park and Levine
reconﬁrmed that dehydroascorbic acid uptake occurred via GLUT 1
or GLUT 3, two glucose transporters in Jurkat, HL-60, U937 and
HeLa cells. This process is independent of sodium in the buffer [60].
Within the cell, DHA is regenerated into ascorbate at the expense of
reduced glutathione (GSH) [61]. However, ascorbate cannot regener-
ate glutathione from its oxidized form (GSSG). Glutathione reductase
is the main enzyme responsible for the regeneration of GSSG to GSH
form in the presence of NADPH. Therefore, GSH, GSSG content and
GR activity are directly dependent on the integrity of the pentose
pathway [62]. In fact, a metabolic relationship between the GSH/
GSSG and ascorbate/DHA redox couples has long been recognized
[61]. Intracellular presence of DHA may not only represent an accu-
mulation of the oxidized form of vitamin C, but may also have a role
in inﬂuencing GSH levels through the activation of the pentose path-
way [63]. Also, Lenton et al. [64] demonstrated an ability of vitamin C
to increase lymphocyte glutathione, suggesting that vitamin C may
also be valuable in the treatment of diseases or conditions involving
glutathione deﬁciency.
The total content of thiol groups or carbonyl groups used as bio-
markers of oxidative stress was not modiﬁed by any of the treatments
(Table 2), although we observed a trend to decreasing carbonyl
groups after astaxanthin/vitamin C treatment. The mild oxidative
changes in the intracellular thiol pool occur not only in pathological
conditions of oxidative stress, but are likely to play an important
role in the normal immune response under physiological condi-
tions [65]. The intracellular concentration of glutathione determines
the cellular thiol-disulﬁde redox potential to a large extent, regulating
a variety of cell processes through the disulﬁde bridge formation and
protein glutathionylation. In particular, proliferation and apoptosis
are very sensitive to changes in the redox potential [66].
In summary, our results showed that treatment of lymphocyteswith
the association of ASTA and vitamin C suggests a powerful antioxidant
effect, based on low levels of superoxide anion, hydrogen peroxide
and GSSG content, associated with elevated levels of enzymes GPx, GR
and G6PDH. The effects of ASTA and vitamin C were more summative
than synergistic, since these antioxidants individually, have different
actions. On the other hand, high glucose and methylglyoxal did not
promote oxidative stress in human lymphocytes, since neither the
oxidative parameters nor the antioxidant defense system was altered.
According to these results, new therapies with the association of
astaxanthin and vitamin Cmay be helpful to improve the immune func-
tion of patients with exacerbated production of ROS as in aging process,
cancer, diabetes, atherosclerosis and neurodegenerative disorders.Conﬂict of interest statement
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